RevivBio Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
12
RevivBio General Information
Description
Operator of a bioengineering and data-driven molecular design platform intended to protect plants and animals from resistant pests and pathogens. The company's platform integrates protein engineering, microfluidics, and AI-driven analytics to generate high-throughput experimental data, enabling biotechnology companies to accelerate the development of functional biologics for crop, human, and animal health.
Contact Information
Website
www.revivbio.comCorporate Office
- 750 Main Street
- Cambridge, MA 02139
- United States
Corporate Office
- 750 Main Street
- Cambridge, MA 02139
- United States
RevivBio Timeline
RevivBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Accelerator/Incubator | 01-Feb-2025 | Completed | Generating Revenue | |||
| 8. Grant | 15-Sep-2024 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 02-Apr-2024 | Completed | Generating Revenue | |||
| 6. Seed Round | 07-Feb-2024 | Completed | Generating Revenue | |||
| 5. Seed Round | 01-Jul-2023 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Apr-2023 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 20-Mar-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 14-Oct-2022 | $100K | $237K | Completed | Generating Revenue | |
| 1. Angel (individual) | 03-Oct-2022 | $137K | $137K | Completed | Generating Revenue |
RevivBio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-3 | ||||||||
| Seed-2 | ||||||||
| Seed-1 | 249,374 | $0.000010 | 6% | $12.03 | $12.03 | 1x | $12.03 | 18.17% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
RevivBio Patents
RevivBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024163931-A1 | Enzymatic degradation of poly and perfluorinated compounds | Inactive | 03-Feb-2023 |
RevivBio Signals
RevivBio Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| US National Science Foundation | Accelerator/Incubator | |||
| Alumni Ventures | Venture Capital | Minority | ||
| BioGenerator Ventures | Venture Capital | Minority | ||
| Seventure | Venture Capital | Minority | ||
| SNO Management | Venture Capital | Minority |
RevivBio FAQs
-
When was RevivBio founded?
RevivBio was founded in 2021.
-
Where is RevivBio headquartered?
RevivBio is headquartered in Cambridge, MA.
-
What is the size of RevivBio?
RevivBio has 9 total employees.
-
What industry is RevivBio in?
RevivBio’s primary industry is Discovery Tools (Healthcare).
-
Is RevivBio a private or public company?
RevivBio is a Private company.
-
What is RevivBio’s current revenue?
The current revenue for RevivBio is .
-
How much funding has RevivBio raised over time?
RevivBio has raised $3.29M.
-
Who are RevivBio’s investors?
US National Science Foundation, Alumni Ventures, BioGenerator Ventures, Seventure, and SNO Management are 5 of 12 investors who have invested in RevivBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process